ArticleFrontiers in immunology2025

Is neoadjuvant immunotherapy feasible for patients with dMMR/MSI-H locally advanced colorectal cancer? a retrospective study.

Zhenkai Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.